Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.78 SEK | -1.79% | -2.23% | -4.98% |
02-23 | Initiator Pharma A/S Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 | CI |
02-21 | Initiator Pharma Issues New Shares for Debt Conversion | MT |
Sales 2023 | - | Sales 2024 * | 161M 23.09M 252M 31.54M | Capitalization | 296M 42.44M 464M 57.98M |
---|---|---|---|---|---|
Net income 2023 | -22M -3.15M -34.47M -4.31M | Net income 2024 * | 103M 14.77M 161M 20.18M | EV / Sales 2023 | - |
Net cash position 2023 | 24.34M 3.49M 38.13M 4.77M | Net cash position 2024 * | 60M 8.6M 94.01M 11.75M | EV / Sales 2024 * | 1.47 x |
P/E ratio 2023 |
-14.1
x | P/E ratio 2024 * |
3.11
x | Employees | 3 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 82.68% |
1 day | -1.79% | ||
1 week | -2.23% | ||
Current month | -3.52% | ||
1 month | -1.79% | ||
3 months | +4.03% | ||
6 months | -3.94% | ||
Current year | -4.98% |
Managers | Title | Age | Since |
---|---|---|---|
Ulf Simonsen
FOU | Founder | 61 | 15-12-31 |
Founder | 50 | 15-12-31 | |
Founder | 56 | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 15-12-31 | |
Chairman | 64 | 15-12-31 | |
Director/Board Member | 66 | 21-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 8.78 | -1.79% | 50,199 |
24-04-25 | 8.94 | 0.00% | 7,660 |
24-04-24 | 8.94 | -0.67% | 12,202 |
24-04-23 | 9 | +2.97% | 23,425 |
24-04-22 | 8.74 | -2.67% | 6,062 |
Delayed Quote Nasdaq Stockholm, April 26, 2024 at 11:29 am
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.98% | 42.37M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- INIT Stock